Promotion of expression of interferon-stimulated genes in U937 monocytic cells by HIV RNAs, measured using stable isotope labeling with amino acids in cell culture (SILAC)

Archives of Virology

Volumn 160, Issue 5, 2015, Pages 1249-1258

  Li, Yulan ^a   Wen, Bin ^a   Chen, Ran ^a   Jiang, Feng ^a   Zhao, Xiaofang ^a   Deng, Xin ^a  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTERFERON; PROTEOME; VIRUS RNA;

CELL LINE; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; ISOTOPE LABELING; METABOLISM; MONOCYTE; TIME; WESTERN BLOTTING;

AMINO ACIDS; BLOTTING, WESTERN; CELL LINE; HIV; HUMANS; INTERFERONS; ISOTOPE LABELING; MONOCYTES; PROTEOME; RNA, VIRAL; TIME FACTORS; TRANSFECTION;

EID: 84930897649     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2372-8     Document Type: Article

References (55)

1. Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–267
2. Rubin BY, Gupta SL (1980) Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci USA 77:5928–5932
3. Bourgeade MF, Chany C, Merigan TC (1980) Type I and type II interferons: differential antiviral actions in transformed cells. J Gen Virol 46:449–454
4. Moussazadeh M, Hua J, Sidhu MK, Zhao XX, Fitzgibbon JE, Liao MJ, Rashidbaigi A (1999) A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitro. Antiviral Res 42:177–187
5. Garcia-Sastre A, Biron CA (2006) Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879–882
6. Oshiumi H, Matsumoto M, Seya T (2012) Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J Biochem 151:5–11
7. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820
8. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis ESC, Matsuura Y, Fujita T, Akira S (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105
9. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107:1512–1517
10. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions. J Clin Invest 115:3265–3275
11. Berg RK, Melchjorsen J, Rintahaka J, Diget E, Soby S, Horan KA, Gorelick RJ, Matikainen S, Larsen CS, Ostergaard L, Paludan SR, Mogensen TH (2012) Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 7:e29291
12. + T cells. Retrovirology 6:5
13. Benlahrech A, Patterson S (2011) HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells. Curr Opin HIV AIDS 6:373–378
14. Collins SE, Noyce RS, Mossman KL (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78:1706–1717
15. Marie I, Durbin JE, Levy DE (1998) Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 17:6660–6669
16. Okumura A, Lu G, Pitha-Rowe I, Pitha PM (2006) Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 103:1440–1445
17. Pincetic A, Kuang Z, Seo EJ, Leis J (2010) The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol 84:4725–4736
18. Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J, Laustsen A, Hansen K, Ostergaard L, Fitzgerald KA, Xiao TS, Mikkelsen JG, Mogensen TH, Paludan SR (2013) IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci USA 110:E4571–E4580
19. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85:2126–2137
20. Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, Mothes W (2013) TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol 87:257–272
21. Everley PA, Krijgsveld J, Zetter BR, Gygi SP (2004) Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics 3:729–735
22. Coombs KM, Berard A, Xu W, Krokhin O, Meng X, Cortens JP, Kobasa D, Wilkins J, Brown EG (2010) Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J Virol 84:10888–10906
23. Munday DC, Hiscox JA, Barr JN (2010) Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS. Proteomics 10:4320–4334
24. Alqahtani A, Heesom K, Bramson J, Curiel D, Ugai H, Matthews D (2014) Analysis of purified wild type and mutant adenovirus particles by SILAC based quantitative proteomics. J Gen Virol 95(Pt 11):2504–2511
25. Jarboui MA, Bidoia C, Woods E, Roe B, Wynne K, Elia G, Hall WW, Gautier VW (2012) Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PLoS One 7:e48702
26. Sun W, Gao S, Wang L, Chen Y, Wu S, Wang X, Zheng D, Gao Y (2006) Microwave-assisted protein preparation and enzymatic digestion in proteomics. Mol Cell Proteomics 5:769–776
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402–408
28. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Das U, Daugherty L, Duquenne L, Finn RD, Gough J, Haft D, Hulo N, Kahn D, Kelly E, Laugraud A, Letunic I, Lonsdale D, Lopez R, Madera M, Maslen J, McAnulla C, McDowall J, Mistry J, Mitchell A, Mulder N, Natale D, Orengo C, Quinn AF, Selengut JD, Sigrist CJ, Thimma M, Thomas PD, Valentin F, Wilson D, Wu CH, Yeats C (2009) InterPro: the integrative protein signature database. Nucleic Acids Res 37:D211–D215
29. Zhou X, Michal JJ, Zhang L, Ding B, Lunney JK, Liu B, Jiang Z (2013) Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci 9:200–208
30. Hickford D, Frankenberg S, Shaw G, Renfree MB (2012) Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 13:155
31. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP (2005) ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25:6338–6345
32. Goujon C, Moncorge O, Bauby H, Doyle T, Barclay WS, Malim MH (2014) Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. J Virol 88:9017–9026
33. Cheng YS, Patterson CE, Staeheli P (1991) Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol Cell Biol 11:4717–4725
34. McAllister CS, Taghavi N, Samuel CE (2012) Protein kinase PKR amplification of interferon β induction occurs through initiation factor eIF-2α-mediated translational control. J Biol Chem 287:36384–36392
35. Servant MJ, Ten OB, LePage C, Conti L, Gessani S, Julkunen I, Lin R, Hiscott J (2001) Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem 276:355–363
36. Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM (1998) Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273:29210–29217
37. Pinney JW, Dickerson JE, Fu W, Sanders-Beer BE, Ptak RG, Robertson DL (2009) HIV-host interactions: a map of viral perturbation of the host system. Aids 23:549–554
38. Ptak RG, Fu W, Sanders-Beer BE, Dickerson JE, Pinney JW, Robertson DL, Rozanov MN, Katz KS, Maglott DR, Pruitt KD, Dieffenbach CW (2008) Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses 24:1497–1502
39. Van Duyne R, Kehn-Hall K, Klase Z, Easley R, Heydarian M, Saifuddin M, Wu W, Kashanchi F (2008) Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication. Expert Rev Proteomics 5:507–528
40. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264
41. Onoguchi K, Yoneyama M, Fujita T (2011) Retinoic acid-inducible gene-I-like receptors. J Interferon Cytokine Res 31:27–31
42. Schoggins JW (2014) Interferon-stimulated genes: roles in viral pathogenesis. Curr Opin Virol 6:40–46
43. Meier A, Alter G, Frahm N, Sidhu H, Li B, Bagchi A, Teigen N, Streeck H, Stellbrink HJ, Hellman J, van Lunzen J, Altfeld M (2007) MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded toll-like receptor ligands. J Virol 81:8180–8191
44. O’Brien M, Manches O, Sabado RL, Baranda SJ, Wang Y, Marie I, Rolnitzky L, Markowitz M, Margolis DM, Levy D, Bhardwaj N (2011) Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype. J Clin Invest 121:1088–1101
45. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M (2009) Sex differences in the toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955–959
46. Chang JJ, Woods M, Lindsay RJ, Doyle EH, Griesbeck M, Chan ES, Robbins GK, Bosch RJ, Altfeld M (2013) Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. J Infect Dis 208:830–838
47. Tian RR, Guo HX, Wei JF, Yang CK, He SH, Wang JH (2012) IFN-lambda inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production. Antiviral Res 95:57–65
48. Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li JL, Wang YZ, Ho WZ (2012) IFN-lambda3 inhibits HIV infection of macrophages through the JAK-STAT pathway. PLoS One 7:e35902
49. + T cells. J Immunol 190:3346–3353
50. Dahari H, Affonso DAE, Haagmans BL, Layden TJ, Cotler SJ, Barone AA, Neumann AU (2010) Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: implications for treatment outcomes. J Hepatol 53:460–467
51. Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, Huang L, Levy JA, Liu YJ (2001) Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98:906–912
52. Lo CC, Schwartz JA, Johnson DJ, Yu M, Aidarus N, Mujib S, Benko E, Hyrcza M, Kovacs C, Ostrowski MA (2012) HIV delays IFN-α production from human plasmacytoid dendritic cells and is associated with SYK phosphorylation. PLoS One 7:e37052
53. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O (2011) Innate sensing of HIV-infected cells. PLoS Pathog 7:e1001284
54. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale MJ (2009) Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol 83:10395–10405
55. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM (2008) HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85–97